Key result
Pranayama reduces heart rate compared to control in hypertensive patients.
Why the study?
Pranayama may modulate cardiovascular function, but its impact on hypertension remains uncertain.
Does pranayama reduce heart rate and blood pressure in adults with hypertension?
Systematic Review (n=683)
Does pranayama reduce heart rate and blood pressure in adults with hypertension?
Standardized Mean Difference: -0.43 (95% CI -0.52–-0.34)
Pranayama as a standalone intervention modestly reduces heart rate and systolic blood pressure, suggesting it may serve as a low-cost, safe adjunctive therapy for hypertension management.
Supports pranayama as low-cost adjunct in hypertension; strengthens RCT evidence base via meta-analysis.
INTRODUCTION: Systemic hypertension is a major contributor to global cardiovascular morbidity and mortality. Effective management combines pharmacological and lifestyle interventions. Pranayama, a yogic breathing technique, may modulate cardiovascular function, but its impact on hypertension remains uncertain. METHODS: A systematic review and meta-analysis following PRISMA guidelines (PROSPERO: CRD42024597502) included RCTs from PubMed, Cochrane Library, Scopus, and ClinicalTrials.gov up to April 2025. We assessed Risk of bias using Cochrane RoB 2, and pooled effects were reported as standardized mean differences (SMDs) with 95 % confidence intervals (CIs). RESULTS: = 0 %). Systolic BP decreased significantly under fixed-effects (SMD = -0.72), while diastolic BP and HRV improvements were modest. CONCLUSION: Pranayama lowers heart rate and may modestly reduce blood pressure, supporting its role as a safe, adjunctive therapy pending larger standardized trials.
No takes yet. Share an insight, caveat, or question.
Chidambaram et al. (2026) conducted a systematic review in Hypertension (n=683). Pranayama (yogic breathing) vs. Standard-of-care or waitlist control groups was evaluated on Heart rate (SMD -0.43, 95% CI -0.52 to -0.34). Pranayama as a standalone intervention significantly reduced heart rate (SMD -0.43) compared to control groups in patients with hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: